Table 1

MM patient characteristics and incidence patterns

Blacks
Whites
Black:white rate ratio
n (%)Incidence (95% CI)n (%)Incidence (95% CI)
Total 5798 (100) 11.0 (10.7-11.3) 28 939 (100) 4.9 (4.8-4.9) 2.25 
Sex      
    Male 2883 (50) 13.2 (12.7-13.7) 15 255 (53) 6.1 (6.0-6.2) 2.16 
    Female 2915 (50) 9.6 (9.2-9.9) 13 684 (47) 4.0 (3.9-4.1) 2.40 
Year of MM diagnosis      
    1973-1979 744 (13) 10.1 (9.3-10.9) 4536 (15) 4.5 (4.4-4.6) 2.24 
    1980-1986 1048 (18) 10.9 (10.3-11.7) 5424 (19) 4.7 (4.6-4.8) 2.32 
    1987-1993 1244 (21) 11.2 (10.5-11.8) 6384 (22) 5.0 (4.9-5.1) 2.24 
    1994-1998 1097 (19) 11.9 (11.2-12.7) 5074 (18) 5.1 (5.0-5.3) 2.33 
    1999-2005 1665 (29) 11.0 (10.5-11.6) 7521 (26) 5.0 (4.9-5.1) 2.20 
Age, y      
    < 50 633 (11) 1.2 (1.1-1.3) 1629 (5) 0.4 (0.4-0.4) 3.00 
    50-69 2787 (48) 24.0 (23.1-24.8) 11 490 (40) 9.7 (9.5-9.9) 2.47 
    ≥ 70 2378 (41) 62.2 (59.7-64.7) 15 820 (55) 30.4 (29.9-30.8) 2.05 
Median age, y (interquartile range) 66 (56-74) 70 (61-78)  
Blacks
Whites
Black:white rate ratio
n (%)Incidence (95% CI)n (%)Incidence (95% CI)
Total 5798 (100) 11.0 (10.7-11.3) 28 939 (100) 4.9 (4.8-4.9) 2.25 
Sex      
    Male 2883 (50) 13.2 (12.7-13.7) 15 255 (53) 6.1 (6.0-6.2) 2.16 
    Female 2915 (50) 9.6 (9.2-9.9) 13 684 (47) 4.0 (3.9-4.1) 2.40 
Year of MM diagnosis      
    1973-1979 744 (13) 10.1 (9.3-10.9) 4536 (15) 4.5 (4.4-4.6) 2.24 
    1980-1986 1048 (18) 10.9 (10.3-11.7) 5424 (19) 4.7 (4.6-4.8) 2.32 
    1987-1993 1244 (21) 11.2 (10.5-11.8) 6384 (22) 5.0 (4.9-5.1) 2.24 
    1994-1998 1097 (19) 11.9 (11.2-12.7) 5074 (18) 5.1 (5.0-5.3) 2.33 
    1999-2005 1665 (29) 11.0 (10.5-11.6) 7521 (26) 5.0 (4.9-5.1) 2.20 
Age, y      
    < 50 633 (11) 1.2 (1.1-1.3) 1629 (5) 0.4 (0.4-0.4) 3.00 
    50-69 2787 (48) 24.0 (23.1-24.8) 11 490 (40) 9.7 (9.5-9.9) 2.47 
    ≥ 70 2378 (41) 62.2 (59.7-64.7) 15 820 (55) 30.4 (29.9-30.8) 2.05 
Median age, y (interquartile range) 66 (56-74) 70 (61-78)  

Patients diagnosed 1973-2005 (SEER-9). All incidence rates are per 100 000 person-years and adjusted using the 2000 US population standard. The present study defined multiple myeloma cases ICD-O-3 codes 9732/3, which includes only cases coded as MM. However, the annually published SEER Cancer Statistics Review uses the Site and Morphology code for “Myeloma,” which includes a biologically and clinically heterogeneous group of plasma cell disorders including MM, solitary plasmacytoma, and plasma cell leukemia.

or Create an Account

Close Modal
Close Modal